FDA
-
healthKao USA Recalls Oribe Shampoo Over Bacterial Contamination Risk
Kao USA is voluntarily recalling specific lots of Oribe Serene Scalp Densifying Shampoo in the U.S. and Canada due to potential contamination.
-
healthNovo Nordisk Opens Affordable Access to Semaglutide Through Medicare GLP-1 Bridge
Novo Nordisk launches a nationwide Medicare program offering its FDA-approved semaglutide injection and pill for a fixed $50 monthly copay through 2027.
-
healthFDA-Approved Biologic Dupilumab Shows Strong Efficacy in Children with Eczema
A systematic review finds dupilumab significantly improves disease severity and quality of life in children with moderate-to-severe atopic dermatitis.
-
techMidjourney Enters Medical Imaging with Water-Based Body Scanner
AI art company Midjourney unveils a spa-style body scanner using ultrasound and water, promising 60-second scans without radiation.
-
healthFDA Issues Major Warning on Breast Biopsy Needle Shortage Until 2027
The FDA warns of a critical shortage of stereotactic breast biopsy needles due to supplier issues, potentially impacting patient care until March 2027.
-
healthFDA Clears First Over-the-Counter CGM for Children
The FDA has authorized the first over-the-counter continuous glucose monitor for children two and older, enabling families to track blood sugar without a prescription and manage prediabetes risks.
-
healthTrump's Possible Role in Controversial Obesity Drug Trial
An investigation reveals possible connections between Donald Trump and a mysterious case involving the experimental obesity drug retatrutide.
-
healthFDA Approves Bemotrizinol, A New Sunscreen Ingredient
FDA's approval of bemotrizinol marks a significant advancement in sunscreen options, enhancing skin protection for consumers.